Wai Kay Seto

Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial

Edward Gane, Wai Kay Seto, Henry Lik‐Yuen Chan et al. · ˜The œLancet. Gastroenterology & hepatology · 2016 · 546 citations

Pharmacy, Infectious Diseases, Pharmacology +12

Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of HBeAg-positive chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial

Henry Lik‐Yuen Chan, Scott Fung, Wai Kay Seto et al. · ˜The œLancet. Gastroenterology & hepatology · 2016 · 458 citations

Pharmacy, Infectious Diseases, Pharmacology +11

96 weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection

Kosh Agarwal, Maurizia Rossana Brunetto, Wai Kay Seto et al. · Journal of Hepatology · 2018 · 423 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +10

Occult hepatitis B infection and HBV replicative activity in patients with cryptogenic cause of hepatocellular carcinoma

Danny Wong, Fung Yu Huang, Ching‐Lung Lai et al. · Hepatology · 2011 · 155 citations · Full text

Medicine, Molecular Biology, Oncology +17

Metformin Use and Gastric Cancer Risk in Diabetic Patients After Helicobacter pylori Eradication

Ka Shing Cheung, Esther W. Chan, Angel Wong et al. · JNCI Journal of the National Cancer Institute · 2018 · 70 citations

Medicine, Pharmacology, Pharmacotherapy +16